CSSC-STC(600072)

Search documents
 中船科技: 中船科技股份有限公司第十届监事会第六次会议决议公告
 Zheng Quan Zhi Xing· 2025-08-06 16:22
证券代码:600072 证券简称:中船科技 公告编号:临 2025-035 二、监事会会议审议情况 (一)审议并通过《关于取消公司监事会及废止 <中船科技股份有限公司监事> 会议事规则>的预案》。 表决结果:同意 3 票,反对 0 票,弃权 0 票。 根据法律法规等相关规定及对《公司章程》的修订,公司不再设置监事会, 《公司法》规定的监事会职权由董事会审计委员会行使,《中船科技股份有限公 司监事会议事规则》相应废止,公司各项制度中涉及监事会、监事的规定不再适 用。公司现任监事职务将自股东大会审议通过本预案之日起相应解除。在此之前, 公司监事会仍将按照《公司法》《公司章程》等相关规定勤勉尽责,履行监督职 能,维护公司和全体股东利益。公司对监事会及全体监事在任职期间为公司所做 的贡献表示衷心感谢! 中船科技股份有限公司 第十届监事会第六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 中船科技股份有限公司(以下简称"公司")第十届监事会第六次会议于 2025 年 8 月 6 日以通讯表决方式召 ...
 中船科技: 中船科技股份有限公司关于召开2025年第二次临时股东大会的通知
 Zheng Quan Zhi Xing· 2025-08-06 16:22
证券代码:600072 证券简称:中船科技 公告编号:临 2025-038 中船科技股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: (三)投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间:2025 年 8 月 22 日 14 点 00 分 召开地点:上海市黄浦区鲁班路 600 号江南造船大厦四楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自2025 年 8 月 22 日 至2025 年 8 月 22 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股东 大会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过互联网投 票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程 ...
 中船科技: 中船科技股份有限公司关于子公司对外投资的公告
 Zheng Quan Zhi Xing· 2025-08-06 16:22
 Investment Overview - The company plans to invest in a 1.3 million kW wind power project in the E'min County of Tacheng, Xinjiang, with a total investment amount of approximately 571.17 million yuan [1][2] - The project will be developed by the company's wholly-owned subsidiary, China Shipbuilding Group Wind Power Development Co., Ltd., through its holding subsidiary, E'min Tower Wind New Energy Co., Ltd. [1][3]   Project Details - The project will consist of a total installed capacity of 1.3 million kW, utilizing a mix of 6.25MW, 10MW, and 15MW turbine models [3] - The initial phase will implement a 750,000 kW wind power project, with a total investment of approximately 353.07 million yuan, including self-raised funds of about 70.61 million yuan and loans of approximately 282.46 million yuan [2][3]   Company Impact - The investment is expected to enhance the company's focus on its core business, promoting the integration of wind turbine equipment and power station systems [4] - Successful completion of the project is anticipated to generate significant economic benefits, increase market share for the company's wind turbine equipment, and improve profitability [4]
 中船科技: 中船科技股份有限公司股东会议事规则
 Zheng Quan Zhi Xing· 2025-08-06 16:22
股东会议事规则 中船科技股份有限公司 (2025 年修订) 第一章 总 则 第一条 为规范中船科技股份有限公司(以下简称"公司")行为,保证 公司股东会能够依法行使职权,维护全体股东的合法权益,根据《中华人民共 和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》(以下简称 《证券法》)、《上市公司股东会规则》(以下简称《股东会规则》)及其他有关 法律、法规和规范性文件及中船科技股份有限公司章程(以下简称"公司章 程")的规定,制定本议事规则。 第二条 公司应严格按照法律、行政法规、本规则及《公司章程》的相关 规定召开股东会,保证股东能够依法行使权力。 公司董事会应当切实履行职责,认真、按时组织股东会。公司全体董事应 当勤勉尽责,确保股东会的正常召开和依法行使职权。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 第四条 公司应当聘请律师出席股东会,对以下问题出具意见并公告: (一)股东会的召集、召开程序是否符合法律、行政法规、本规则和公司 章程的规定; (二)出席会议人员资格、召集人资格是否合法有效; (三)会议的表决程序、表决结果是否合法有效; (四)应公司要求对其他问题出具法 ...
 中船科技: 中船科技股份有限公司独立董事管理办法
 Zheng Quan Zhi Xing· 2025-08-06 16:22
中船科技股份有限公司 独立董事管理办法 第一章 总则 第一条 为进一步完善中船科技股份有限公司(以下简称"公司")法人治 理结构,规范公司独立董事履职,发挥独立董事在公司治理中的作用,根据《中 华人民共和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》《上 市公司独立董事管理办法》(以下简称《独立董事管理办法》)、《上海证券交 易所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》(以下简称《自律监管指引第 1 号》)等国家有关法律、法规及规范性文件 和《公司章程》之有关规定,特制定本办法。 第二条 本办法所称独立董事是指不在公司担任除董事和专门委员会以外的 其他职务,并与公司及公司主要股东、实际控制人不存在直接或间接利害关系, 或者其他可能影响其进行独立客观判断关系的董事。 第三条 公司董事会成员中应当至少包括三分之一独立董事,其中至少有一 名会计专业人士。 第四条 公司董事会下设战略、薪酬与考核、审计、提名等专门委员会,独 立董事应当在审计委员会、提名委员会、薪酬与考核委员会成员数量超过半数, 并由独立董事担任召集人。其中,审计委员会召集人(主任委员)应当由独立董 事中 ...
 中船科技: 中船科技股份有限公司董事会薪酬与考核委员会实施细则
 Zheng Quan Zhi Xing· 2025-08-06 16:22
第一章 总则 中船科技股份有限公司 董事会薪酬与考核委员会实施细则 (2025 年修订) 第八条 公司董事会办公室为薪酬与考核委员会工作联系部门,公司其他部 门根据职能提供业务支撑工作。 第三章 职责权限 第一条 为进一步建立健全中船科技股份有限公司(以下简称"公司")董 事(非独立董事)及高级管理人员的考核和薪酬管理制度,完善公司治理结构, 根据《中华人民共和国公司法》《上市公司治理准则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作等》等法律、法规、规范性文件及《公司章 程》的有关规定,公司特设立董事会薪酬与考核委员会,并制定本实施细则。 第二条 薪酬与考核委员会是董事会设立的专门工作机构,主要负责制定公 司董事及高级管理人员的考核标准并进行考核;负责制定、审查公司董事及高级 管理人员的薪酬政策与方案,对董事会负责。 第三条 本细则所称高级管理人员是指董事会聘任的经理、副经理、财务负 责人、董事会秘书及由经理提请董事会认定的其他高级管理人员。 第二章 人员组成 第四条 薪酬与考核委员会成员由三名董事组成,独立董事占多数。 第五条 薪酬与考核委员会委员由董事长、二分之一以上独立董事或者全体 董 ...
 中船科技: 中船科技股份有限公司董事会提名委员会实施细则
 Zheng Quan Zhi Xing· 2025-08-06 16:22
第二条 董事会提名委员会是董事会按照股东大会决议设立的专门工作机构, 主要负责对公司董事和高级管理人员的人选、选择标准和程序进行选择并提出建 议。 第二章 人员组成 第三条 提名委员会成员由三名董事组成,独立董事占多数。 中船科技股份有限公司 董事会提名委员会实施细则 (2025 年修订) 第一章 总则 第一条 为规范中船科技股份有限公司(以下简称"公司")董事、高级管 理人员的选聘工作,优化董事会组成,完善公司治理结构,根据《中华人民共和 国公司法》《上市公司治理准则》《上海证券交易所上市公司自律监管指引第 1 号—规范运作》等有关法律、法规和规范性文件及《公司章程》的有关规定,公 司特设立董事会提名委员会,并制定本实施细则。 第四条 提名委员会委员由董事长、二分之一以上独立董事或者全体董事的 三分之一提名,并由董事会选举产生。 第五条 提名委员会设主任委员(召集人)一名,由独立董事委员担任,负 责主持委员会工作;主任委员在委员内选举,并报请董事会批准产生。 第六条 提名委员会任期与董事会任期一致,委员任期届满,连选可以连任。 期间如有委员不再担任公司董事职务,自动失去委员资格,并由委员会根据上述 第三至第 ...
 每天三分钟公告很轻松 | 百济神州:上半年实现净利润4.5亿元同比扭亏为盈
 Shang Hai Zheng Quan Bao· 2025-08-06 15:56
 Group 1 - BeiGene reported a net profit of 450 million yuan for the first half of 2025, reversing a loss of 287.7 million yuan in the same period last year, with a total revenue of 17.518 billion yuan, up 46.0% year-on-year [1] - The company attributed the profit increase to significant growth in product revenue and improved operational efficiency through cost management [1]   Group 2 - Tianyang Technology is planning to acquire a portion of the equity in Tonglian Financial Services Co., Ltd. and related companies, aiming to enhance its competitive advantage in credit card and consumer finance system services [2] - The acquisition is expected to create synergies in areas such as industry positioning, product development, and technical services [2]   Group 3 - ST Yazhen's stock experienced abnormal trading fluctuations, with a cumulative price increase of 12% over three consecutive trading days, leading to a suspension of trading for investigation starting August 7, 2025 [3] - The company noted that the short-term price increase significantly deviated from the Shanghai Composite Index and the furniture manufacturing industry [3]   Group 4 - Shunbo Alloy reported a revenue of approximately 7.126 billion yuan for the first half of 2025, an increase of 11.75% year-on-year, with a net profit of about 176.6 million yuan, up 110.56% [4] - Tapa Group achieved a revenue of approximately 2.056 billion yuan, a 4.05% increase year-on-year, with a net profit of about 435.4 million yuan, up 92.47% [4] - Liyuan Information reported a revenue of approximately 4.034 billion yuan, a 17.46% increase year-on-year, with a net profit of about 96.1 million yuan, up 65.79% [5]   Group 5 - Zhongchumei reported a revenue of approximately 461.1 million yuan for the first half of 2025, a 16.46% increase year-on-year, with a net profit of about 126.8 million yuan, up 31.52% [5] - Pudong Development Bank reported a revenue of approximately 90.559 billion yuan, a 2.62% increase year-on-year, with a net profit of about 29.737 billion yuan, up 10.19% [5]
 百济神州:上半年净利润4.5亿元 同比扭亏为盈丨公告精选
 2 1 Shi Ji Jing Ji Bao Dao· 2025-08-06 14:20
 Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved an operating income of 4.258 billion yuan and a net profit of 1.123 billion yuan in the first half of 2025, with total comprehensive income of 1.106 billion yuan [3] - Shanghai Pudong Development Bank's net profit for the first half of 2025 was 29.737 billion yuan, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [6] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [7] - Shengmei Shanghai reported a net profit of 696 million yuan for the first half of 2025, representing a year-on-year increase of 56.99% [14]   Group 2: Regulatory and Corporate Actions - Sino Medical's subsidiary received breakthrough medical device designation from the FDA for its intracranial atherosclerosis treatment product, marking it as the first of its kind globally [2] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Tianyang Technology is planning to purchase equity in Tonglian Financial Services, with key transaction details still under negotiation [10] - Dongfang Guoxin's major shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [5] - Filinger's president reduced his holdings by 8,600 shares during a period of stock price volatility, while other executives did not sell shares [4]
 百济神州:上半年净利润4.5亿元,同比扭亏为盈丨公告精选
 2 1 Shi Ji Jing Ji Bao Dao· 2025-08-06 14:20
 Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved a net profit of 1.123 billion yuan in the first half of 2025, with total operating income of 4.258 billion yuan and total comprehensive income of 1.106 billion yuan [1] - Shanghai Pudong Development Bank reported a net profit of 29.737 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [4] - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [5] - Shunbo Alloy reported a net profit growth of 110.56% year-on-year for the first half of 2025 [12]   Group 2: Regulatory and Corporate Actions - Sino Medical announced that its subsidiary received breakthrough medical device designation from the FDA for a new intracranial atherosclerosis treatment product, marking a significant milestone as the first of its kind globally [1] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6][7] - Tianyang Technology is planning to purchase equity in Tonglian Jinfu and related companies, with key transaction details still under negotiation [8] - Filinger reported stock price fluctuations, with the president reducing his holdings by 8,600 shares during a period of abnormal trading activity [2] - Dongfang Guoxin's controlling shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [3]


